<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669920/" ref="ordinalpos=3906&amp;ncbi_uid=4958138&amp;link_uid=PMC3669920" image-link="/pmc/articles/PMC3669920/figure/fig2/" class="imagepopup">Figure 2.  From: Multiple variants aggregate in the neuregulin <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in a subset of schizophrenia patients. </a></div><br /><div class="p4l_captionBody">Pathway clustering model. Schematic representation of the proposed pathway clustering model for schizophrenia demonstrating how clustering of multiple protein damaging variants within different well-defined molecular pathways could represent an unrecognized factor of SZ risk and phenotypic heterogeneity.</div></div>